Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
Filter News
Show All Results
News By Country
News By Tag
Cardiovascular Remove
Related Tags


February 2012
Su Sa Fr Th We Tu Mo
19 18 17 16 15 14 13

cardiovascular News

  + XML/RSS  



By Sarah Brereton, Limewash Media & Design Ltd
Chesterford Research Park’s health and fitness team kick start 2012 with two new classes

By Sarah Brereton, Limewash Media & Design Ltd
Matt Snelling joins Nucleus team to give additional motivational encouragement to gym members!

By Drew Diaz
Representatives from Heart Test Laboratories traveled to Dusseldorf, Germany, to represent the company at MEDICA 2011, World Forum for Medicine International Trade Fair.

By South Nassau Communities Hospital
To earn the award, South Nassau needed to adhere to the treatment guidelines in ACTION Registry–GWTG for 12 consecutive quarters (three years) and meet a performance standard of at least 85% for specific performance measures.

By SMi Group
How to select the most apporpriate formulation tool for poorly soluble drugs

By Jeffrey Beck Fitness
Dylan had been on an artificial heart for nearly a year before receiving a heart transplant in June 2010. Just 21 years old, he had been dealing with heart problems since childhood which didn't leave him with a high quality of life.

By Meg Walker
Sutter Pacific Medical Foundation announced the addition of two new specialty care physicians. Robert Rho, M.D., joins the Foundation as a specialist in cardiovascular disease and electrophysiology. Jyoti Jain, M.D., is a psychiatrist

By Netscribes
Netscribes (India) Pvt. Ltd., launches its Cardiac Pacemaker Industry India Report 2011 covering one of the emerging markets in India with strong growth prospects . It is a part of Netscribes’ Healthcare Series reports.

By Frost & Sullivan
Advanced Applications to Drive Market Revenues to $583.6 Million By 2016

By Blair Poetschke
Two biomedical measurement companies merge to offer fully integrated cardiovascular measurement solutions for both pre-clinical and clinical products.

By Natalia Sturtz-Verastegui
White Plains Hospital has been granted accreditation by the ICAEL for their Echocardiography Lab, recognizing the laboratory’s commitment to quality testing for heart disease diagnosis.

By Global Markets Direct
The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders

By FEBICO
FEBICO Chlorella Vulgaris CV-66 contains levels of rich natural PPARs (Peroxisome proliferator activated receptor), and GLA which are much higher than the usual chlorella, which effectively reduces your risk of diseases.

By Tobi Ferguson
Golf ‘Fore’ Your Heart Raises over $125,000 for Cardiovascular Health Institute

By South Nassau Communities Hospital
The Revo MRI™ SureScan® pacing system, the first and only pacemaker in the U.S. specifically designed for use in a MRI environment, was approved by the U.S. Food and Drug Administration (FDA) On February 8, 2011.

By David Eastman
Gamma Therapeutics, an Oregon biotech venture announced its been awarded a Phase II SBIR grant from the NIH to commercialize its GammaCoeur CVD Risk Assay. The $1.1 M grant allows GT to complete development, testing & final FDA approval by 2012.

By Fast Market Research
New Pharmaceuticals market report from Datamonitor: "Commercial Insight: Cardiovascular and Metabolic Market Forecast"

By HeartSmart Technologies
HeartSmart Technologies Eye Care Division is pleased to announce that Kathleen Andersen, OD and Niloufar Hedayat, OD of RSM Vision in Rancho Santa Margarita, California have joined the HeartSmart Associates Network.

By FitMed Partners
FitMed Partners offers Lipid Plus testing to patients. Fifty percent of heart attack victims have normal cholesterol, proving a simple cholesterol check is not enough to establish good cardiovascular health.

By reportsnreports.com
In recent years, the prevalence rate of cardiovascular disease has increased year by year. According to the data issued by Ministry of Health of the People’s Republic of China, there were 20 million patients with coronary artery disease in China

By Asante Health System
Join cardiologist Brian Gross MD, Southern Oregon Cardiology, for “Heart Disease and Seniors,” on March 16 from 11:30 a.m. to 1 p.m. at the Smullin Health Education Center on the Rogue Valley Medical Center campus in Medford. Lunch is free.

By reportsnreports.com
This report is an essential source for in-depth information and data relating to the Germany cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume

By reportsnreports.com
This medical equipment report is an essential source for key information and data relating to the Global cardiovascular devices market. The report provides overview of key trends, drivers and restraints

By reportsnreports.com
This report is an essential source for in-depth information and data relating to the US cardiovascular devices market. It also offers detailed

By reportsnreports.com
GlobalData’s “Spain Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Spain cardiovascular devices market. The report provides market landscape

By reportsnreports.com
GlobalData’s medical device report: “Australia Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Australia cardiovascular devices market.

By reportsnreports.com
GlobalData’s medical device report: “Canada Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Canada cardiovascular devices market.

By reportsnreports.com
The cardiovascular devices represent one of the major markets in the medical equipment industry. This market consists of Cardiac Rhythm Management (CRM) devices

By reportsnreports.com
GlobalData’s medical device report offering, “Republic of Korea Cardiovascular Devices Market Outlook to 2016” provides key market data on the Republic of Korea cardiovascular devices market.

By reportsnreports.com
GlobalData’s new report, “The UK Cardiovascular Devices Market Outlook to 2016” provides key market data on the United Kingdom cardiovascular devices market. The report provides value (USD million)

By reportsnreports.com
GlobalData’s medical equipment report, “Israel Cardiovascular Devices Market Outlook to 2016” provides key market data on the Israel cardiovascular devices market. The report provides value

By reportsnreports.com
GlobalData’s medical equipment report, “Mexico Cardiovascular Devices Market Outlook to 2016” provides key market data on the Mexico cardiovascular devices market. The report provides value

By reportsnreports.com
GlobalData’s medical equipment report, “Brazil Cardiovascular Devices Market Outlook to 2016” provides key market data on the Brazil cardiovascular devices market.

By reportsnreports.com
Now in its fifth year of publication, the latest release of Who’s Developing What in Cardiovascular Devices? provides the ideal opportunity to review the progress, and monitor the prospects, of both emerging and established industry participants

By reportsnreports.com
GlobalData’s medical device report offering, “China Cardiovascular Devices Market Outlook to 2016” provides key market data on the China cardiovascular devices market. The report provides value

By David Eastman, CEO
Health Diagnostic Laboratory, Richmond, VA & Gamma Therapeutics,Portland, OR, biotech venture start-ups, are collaborating on the development of a novel cardiovascular disease diagnostic assay to assess CVD patient risk of heart attack or stroke.

By Sally Malech
Sabino Torre, M.D., an Interventional Cardiologist at Saint Barnabas Medical Center in Livingston, NJ, has already seen about a half-dozen men this season who have all had heart attacks after snow shoveling.

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By South Nassau Communities Hospital
The grant will support the construction of a new electrophysiology laboratory and procedure room for diagnostic studies to determine the source of arrhythmia symptoms and to perform treatment procedures.

By Part City
Party City has launched a national campaign in support of the American Heart Association's Go Red for Women, collecting donations for cardiovascular health education at 600+ Party City stores.

By The Publishing Firm
The Publishing Firm has created a unique platform that allows public and privately held companies, philanthropic organizations and government agencies to come together while accomplishing their individual goals.

By Bharatbook
Bharatbook added a new report on "The Cardiovascular Market Outlook to 2014: Competitive landscape, global market analysis and pipeline analysis" into its market report catalogue for reselling.

By South Nassau Communities Hospital
Mr. Morvillo, a member of South Nassau’s board of directors, was the Carnation Ball’s honoree. Ms. Mooney was presented South Nassau’s prestigious Mary Pearson Award.

By Mary Ann Liebert, Inc.
Mounting evidence linking childhood obesity to an increasing risk of obesity, heart disease, type 2 diabetes, and other cardiovascular and metabolic disorders in adulthood is clearly presented in a comprehensive review article.

By Sara Pierre
tebu-bio will be attending the forthcoming ISNN congress "From reference intakes to personalized nutrition", which will take place in Pamplona, Spain, from November 18th to 20th, 2010.

By Fast Market Research
New Medical Devices market report from GlobalData: "Sorin S.p.A. Market Share Analysis"

By Fast Market Research
Fast Market Research recommends "Cardiac Science Corporation Market Share Analysis" from GlobalData, now available

By Fast Market Research
New Medical Devices market report from GlobalData: "St. Jude Medical, Inc Market Share Analysis"

By Kalorama Information
Growth is partly derived from an increased number of cardiovascular procedures and the need to run the activated coagulation time (ACT) test on individuals receiving heparin.

By reports-research.com
Due to safety concerns, sales of GlaxoSmithKline's Avandia will be suspended in Europe, while the FDA has restricted its availability. The drastic drop in sales that such measures will cause presents an opportunity for other drug classes to grow.



Page:



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share